ROK
48
-3
RCL
73
-4
PEG
65
22
AA
34
-3
MRO
46
3
HBAN
44
2
NEE
49
2
MET
60
-3
WAT
36
-2
REGN
65
-3
AIG
53
2
DTE
47
2
NEM
41
3
AXP
62
-2
PAYX
47
2
JCI
33
2
AEP
61
5
MPC
44
-5
ADI
57
-2
DFS
51
-3
ROK
48
-3
RCL
73
-4
PEG
65
22
AA
34
-3
MRO
46
3
HBAN
44
2
NEE
49
2
MET
60
-3
WAT
36
-2
REGN
65
-3
AIG
53
2
DTE
47
2
NEM
41
3
AXP
62
-2
PAYX
47
2
JCI
33
2
AEP
61
5
MPC
44
-5
ADI
57
-2
DFS
51
-3
Financhill
Back

First Trust NASDAQ® Cln Edge®StGidIfsETF Vs. Ultragenyx Pharmaceutical Industry Stock Comparison

Sell
42

GRID
First Trust NASDAQ® Cln Edge®StGidIfsETF

Last Price:
115.36
Seasonality Move:
2.69%
Sell
47

RARE
Ultragenyx Pharmaceutical

Last Price:
41.06
Seasonality Move:
-0.9%
Sell
42
First Trust NASDAQ® Cln Edge®StGidIfsETF (GRID) is a Sell

Is First Trust NASDAQ® Cln Edge®StGidIfsETF a Buy, Sell or Hold?

  • The current First Trust NASDAQ® Cln Edge®StGidIfsETF [GRID] share price is $115.85. The Score for GRID is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
  • GRID is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
47
Ultragenyx Pharmaceutical (RARE) is a Sell

Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?

  • The current Ultragenyx Pharmaceutical [RARE] share price is $41.42. The Score for RARE is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
  • RARE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

GRID Stock Price Chart

What is First Trust NASDAQ® Cln Edge®StGidIfsETF's stock price today?

  • The First Trust NASDAQ® Cln Edge®StGidIfsETF share price today is $115.85
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GRID is experiencing buying pressure, which is a positive indicator for future bullish movement.

RARE Stock Price Chart

What is Ultragenyx Pharmaceutical's stock price today?

  • The Ultragenyx Pharmaceutical share price today is $41.42
    The current trend is relatively stagnant and RARE is experiencing buying pressure, which is a positive indicator for future bullish movement.

GRID Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.34 Sell
Relative Strength Index (14 RSI): 40.6 Sell
Chaikin Money Flow: 93404 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (117.8 - 120.72) Sell
Bollinger Bands (100): (108.54 - 118.92) Buy

RARE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.45 Sell
Relative Strength Index (14 RSI): 52.47 Buy
Chaikin Money Flow: 873891 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (38.82 - 42.02) Buy
Bollinger Bands (100): (40.78 - 48.78) Sell

GRID Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 117.93 Sell
20-day SMA: 118.91 Sell
50-day SMA: 117.35 Sell
200-day SMA: 105.01 Buy
8-day EMA: 117.53 Sell
20-day EMA: 118.37 Sell
50-day EMA: 117.18 Sell
200-day EMA: 108.49 Buy

RARE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 39.5 Buy
20-day SMA: 40.58 Buy
50-day SMA: 41.51 Sell
200-day SMA: 42.46 Sell
8-day EMA: 40.23 Buy
20-day EMA: 40.49 Buy
50-day EMA: 41.77 Sell
200-day EMA: 43.33 Sell

First Trust NASDAQ® Cln Edge®StGidIfsETF Earnings Growth & GRID Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.51 per share, an increase next quarter of $0.03 per share, an increase this year of $0.94 per share, and an increase next year of $1.06 per share.

First Trust NASDAQ® Cln Edge®StGidIfsETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Ultragenyx Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):